Search results for: 'NGS in CQA'

Predictive genetic testing (PGT) comprises analysis of genes, the whole genome, or exomes to predict the risk of a wide range of disorders. It can have long-term implications in preventive healthcare practices, including delayed onset of disease, treatment management, pharmacogenomics, and general wellness. One outcome of the COVID-19 pandemic has ...

This research service offers a comprehensive analysis of the global genetic testing industry (specifically, germline genetic testing, which analyzes inherited genetic variations present in an individual from birth and can be passed to offspring). The industry growth is driven by a shift towards preventive care, rising maternal ages, increasing gove...

Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...

Interest in the microbiome as a science and industry has exploded over the past decade. Innovations are happening across 3 significant categories for human health benefits: microbiome-based therapeutics, over-the-counter (OTC) dietary supplements, and self-diagnostics/screening. The OTC market is the largest because of the lack of precise regulatio...

GCC accounts only for 1.2% of the global HC revenue, but it is the region that saw the highest growth rate in the last decade. GCC has opened doors to global suppliers and moved beyond US imports, which is likely to be the game changer in the 2020s. Technology and digitization are in higher demand than ever before because of higher awareness and ...

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....

This study analyzes the regulatory framework of the connected vehicle (CV) sector’s various segments in Europe, North America (NA), and China. The increase in embedded navigation systems and fifth-generation (5G) technology will drive several new CV features through an app or service. The deployment of over-the-air (OTA) software updates and person...

11 Feb 2020  |  Asia Pacific  |  Market Research

Commercial MRO Market in Japan, S. Korea, and China, 2019

Commercial MRO Market Spending Hovers Around USD 13.0 Billion among Top-3 Nations of NE Asia in 2019

Infographics

×

This study aims to evaluate the commercial aircraft fleet and spending on MRO services among the top 3 Northeast Asian nations consisting of China, South Korea, and Japan boasting a combined airline fleet size of close to 5,000 aircraft at the end of 2019. The study focuses on the fleet and MRO spending comparisons among these top 3 N.E. Asian nati...

12 Feb 2020  |  Asia Pacific  |  Market Research

Commercial MRO Market in Southeast Asia, 2019

Commercial MRO Market Hovers Around US$4.7 Billion Among Top 6 ASEAN Nations in 2019

Infographics

×

This study aims to evaluate the commercial aircraft fleet and spending on MRO services among the top 6 ASEAN nations of Southeast Asia. These countries had a large, combined airline fleet size of close to 1,800 aircraft by the end of 2019. The study focuses on the fleet and MRO spending comparisons among these top 6 ASEAN nations. It further delves...